William Blair initiated coverage on Alcon Inc. (NYSE:ALC) … performance of Alcon's dry eye disease drug, Tryptyr. Alcon… (launching 2026) surgical platforms. Alcon has about 30,000 legacy … Analyst also adds that Alcon could see higher consumables usage …

… to transfer pricing adjustments. Alcon Laboratories (India) Pvt. Ltd … lenses, spare parts and pharmaceutical products in India, along … assessment year 2018–19, Alcon Laboratories (India) Private … assessment order significantly enhanced Alcon India’s taxable …

Dive Brief: STAAR Surgical’s CEO is stepping down after the implantable eye lens manufacturer opposed a $1.6 billion takeover. Encouraged by activist investor Broadwood Partners, STAAR shareholders rejected Alcon’s $1.6 billion offer last week. Thursday, …

STAAR Surgical has announced that it will terminate the proposed acquisition by Alcon based on preliminary estimates by STAAR’s proxy solicitor showing that the company did not receive the necessary stockholder votes to approve the merger agreement with …

… Pharma Limited has received approval from the United States Food and Drug … drug Pataday Once Daily Relief, 0.7%, marketed by Alcon … Regulations, 2015, Gland Pharma stated that the USFDA … injectable and ophthalmic-focused pharmaceutical company with operations …

… infrastructure demand. Gland Pharma Ltd (Gland or … pharmaceutical company, has received approval from the United States Food and Drug … its Abbreviated New Drug Application filed for … drug (RLD), Pataday Once Daily Relief, 0.7%, of Alcon Laboratories Inc (Alcon …

Dive Brief: STAAR Surgical shareholders have voted to reject Alcon’s revised acquisition offer after a contentious proxy battle. The maker of implantable lenses for the eye intends to terminate its merger agreement with Alcon, STAAR said Tuesday, based on …

… AEG Vision, Alcon Vision, Alcon Laboratories, Inc., Alexion Pharmaceuticals, Inc., Alkeus Pharmaceuticals, Inc, Amgen … , Apellis Pharmaceuticals, Inc., Astellas Pharma …

… pharmaceutical company, has received approval from the United States Food and Drug … listed drug Pataday Once Daily Relief 0.7%, marketed by Alcon Laboratories … world’s largest injectable-focused pharmaceutical companies. The company operates predominantly …

This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product The FDA is aware that …